Matrix metalloproteinase-9 delays wound healing in a murine wound model
Zhao Q, Chen YY, Xu DQ, et al
adults would meet SELECT trial eligibility criteria
10.1111/j.1742-1241.2011.02656.x Summary Keywords incretin hormones, GLP-1 receptor agonists, DPP-4 inhibitors, cardiovascular outcomes trials, clinical trials, incretin biology, type 2 diabetes Citation Gilbert MP and Pratley RE (2020) GLP-1 Analogs and DPP-4 Inhibitors in Type 2 Diabetes Therapy: Review of Head-to-Head Clinical Trials
Fifth, GLP-1RAs protect against cardiomyocyte apoptosis under diabetic conditions via activating the leucine zipper motif (APPL 1 )-AMPK-PPAR axis and the AMPK-TXNIP pathway [80, 161]
Nfatc1: Transcription factor T nuclear factor 1